Dr Harsh Shah
Dr Harsh Shah is a New York-based life sciences strategist, researcher and commercial value advisory leader whose work spans clinical research, life sciences technology, commercial strategy, digital transformation, and value realisation across global pharmaceutical and healthcare organisations.
His work focuses on how emerging technologies and clinical-development strategies translate into practical adoption, utilisation and measurable operational value across North America, Europe and Asia-Pacific. He also advises senior leaders across the life sciences and healthcare ecosystem on growth, transformation, operating models and technology investment.
Shah holds a doctorate focused on clinical research, with research examining Asian representation and diversity in US clinical trials, as well as an MBA in Finance. His broader writing and research interests include global clinical-trial strategy, patient representation, clinical-technology adoption and what he describes as the “last mile of life sciences innovation” – converting scientific and technological innovation into meaningful real-world impact.
ArticleWhy better technology does not always lead to better R&D decisions
Making better decisions in drug discovery is not down to implementing more tools. Here, Dr Harsh Shah reveals why teams must start by defining the scientific question.